Yahoo Web Search

Search results

1. • 

     Medicare is negotiating drug prices. Here's why that matters.

     The Port Lavaca Wave· 2 days ago

     For now, only 10 drugs are up for negotiation, including Eliquis and Xarelto for blood clots and...

2. • 

     Four Might Be the Magic Number for Anticoagulation of Subclinical Afib

     MedPage Today· 7 days ago

     In deciding on anticoagulation with apixaban (Eliquis) for patients with device-detected,...

3. • 

     This Unpopular Dividend Stock Is a Buy

     Motley Fool via Yahoo Finance· 3 days ago

     BMS is facing one of the steepest patent cliffs in the industry come 2028 when cancer medication Opdivo and blood thinner Eliquis could both face generic...

4. • Equities Analysts Issue Forecasts for Pfizer Inc.’s Q3 2025 Earnings (NYSE:PFE)

     ETF DAILY NEWS· 2 days ago

     Pfizer Inc. (NYSE:PFE – Free Report) – Stock analysts at Zacks Research dropped their Q3 2025 EPS estimates for Pfizer in a research report issued on Wednesday, May 22nd. Zacks Research analyst ...

5. • 

     Time to Pounce: 2 Ultra-High-Yield S&P 500 Dividend Stocks That Are Screaming Buys Right Now

     Motley Fool via Yahoo Finance· 5 days ago

     To add to the above, many of Pfizer's most-important therapies are breaking through new ceilings....

6. • 

     Pfizer to Cut Costs in Multi-Year Effort

     The Wall Street Journal· 4 days ago

     Pfizer is launching a multi-year cost reduction program expected to include operational efficiencies, network structure changes, and product portfolio...

7. • 

     3 Stocks That Can Help You to Get Richer in 2025 and Beyond

     Motley Fool via Yahoo Finance· 2 days ago

     CEO Albert Bourla credited "revenue from several of our recent commercial launches and acquired...

8. • 

     Bristol Myers (BMY) Updates Action Date for Subcutaneous Opdivo

     Zacks via Yahoo Finance· 4 days ago

     However, the decline in Opdivo sales was a dampener. One of the top drugs, Revlimid, is already...

9. • 

     5 Undervalued Stocks That Crushed Earnings for Q1 2024

     Morningstar· 3 days ago

     Combining the results of firms in the Morningstar US Market Index that have reported earnings with...

10. • Anavex Life Sciences Announces Expansion of Leadership Team

      Morningstar· 4 days ago

      NEW YORK, May 22, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics ...